Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3633

1.

Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study.

Zhou L, Li HY, Wang JH, Deng ZZ, Shan YL, Tan S, Shi YH, Zhang MX, Liu SX, Zhang BJ, Hong MF, Lu ZQ, Huang XM.

Medicine (Baltimore). 2018 Sep;97(38):e12470. doi: 10.1097/MD.0000000000012470.

2.

Low expression of aging-related NRXN3 is associated with Alzheimer disease: A systematic review and meta-analysis.

Zheng JJ, Li WX, Liu JQ, Guo YC, Wang Q, Li GH, Dai SX, Huang JF.

Medicine (Baltimore). 2018 Jul;97(28):e11343. doi: 10.1097/MD.0000000000011343. Review.

3.

Using Drosophila Models of Amyloid Toxicity to Study Autophagy in the Pathogenesis of Alzheimer's Disease.

O'Keefe L, Denton D.

Biomed Res Int. 2018 May 20;2018:5195416. doi: 10.1155/2018/5195416. eCollection 2018. Review.

4.

Shiatsu as an adjuvant therapy for depression in patients with Alzheimer's disease: A pilot study.

Lanza G, Centonze SS, Destro G, Vella V, Bellomo M, Pennisi M, Bella R, Ciavardelli D.

Complement Ther Med. 2018 Jun;38:74-78. doi: 10.1016/j.ctim.2018.04.013. Epub 2018 May 5.

PMID:
29857884
5.

Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.

Duncan RS, Song B, Koulen P.

Int J Mol Sci. 2018 May 31;19(6). pii: E1621. doi: 10.3390/ijms19061621. Review.

6.

Identifying key genes, pathways and screening therapeutic agents for manganese-induced Alzheimer disease using bioinformatics analysis.

Ling J, Yang S, Huang Y, Wei D, Cheng W.

Medicine (Baltimore). 2018 Jun;97(22):e10775. doi: 10.1097/MD.0000000000010775.

7.

Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder.

Lozupone M, La Montagna M, D'Urso F, Piccininni C, Sardone R, Dibello V, Giannelli G, Solfrizzi V, Greco A, Daniele A, Quaranta N, Seripa D, Bellomo A, Logroscino G, Panza F.

Expert Opin Pharmacother. 2018 Jun;19(8):823-842. doi: 10.1080/14656566.2018.1471136. Epub 2018 May 4. Review.

PMID:
29726758
8.

The genetic landscape of Alzheimer disease.

Carmona S, Hardy J, Guerreiro R.

Handb Clin Neurol. 2018;148:395-408. doi: 10.1016/B978-0-444-64076-5.00026-0. Review.

PMID:
29478590
9.

Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.

Giau VV, Lee H, Shim KH, Bagyinszky E, An SSA.

Clin Interv Aging. 2018 Feb 7;13:221-233. doi: 10.2147/CIA.S155145. eCollection 2018. Review.

10.

ATP binding cassette subfamily A member 7 rs3764650 polymorphism and the risk of Alzheimer's disease.

Zhou G, Mao X, Chu J, Chen G, Zhao Q, Wang L, Luo Y.

Pharmazie. 2017 Jul 3;72(7):425-427. doi: 10.1691/ph.2017.6862. Review.

PMID:
29441941
11.

Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.

Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, Fossati S.

EBioMedicine. 2018 Feb;28:21-30. doi: 10.1016/j.ebiom.2018.01.021. Epub 2018 Jan 31. Review.

13.

Dysregulation of Alzheimer's disease-related genes and proteins following cardiac arrest.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

Folia Neuropathol. 2017;55(4):283-288. doi: 10.5114/fn.2017.72384. Review.

14.

The Association between 5HT2A T102C and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease: A Meta-Analysis.

Tang L, Wang Y, Chen Y, Chen L, Zheng S, Bao M, Xiang J, Luo H, Li J, Li Y.

Biomed Res Int. 2017;2017:5320135. doi: 10.1155/2017/5320135. Epub 2017 Nov 16. Review.

15.

Noncoding RNAs in Alzheimer's disease.

Idda ML, Munk R, Abdelmohsen K, Gorospe M.

Wiley Interdiscip Rev RNA. 2018 Mar;9(2). doi: 10.1002/wrna.1463. Epub 2018 Jan 12. Review.

PMID:
29327503
16.

Tau Proteins and Tauopathies in Alzheimer's Disease.

Chong FP, Ng KY, Koh RY, Chye SM.

Cell Mol Neurobiol. 2018 Jul;38(5):965-980. doi: 10.1007/s10571-017-0574-1. Epub 2018 Jan 3. Review.

PMID:
29299792
17.

Practical considerations for choosing a mouse model of Alzheimer's disease.

Jankowsky JL, Zheng H.

Mol Neurodegener. 2017 Dec 22;12(1):89. doi: 10.1186/s13024-017-0231-7. Review.

18.

Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis.

Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS; CoSTREAM Consortium, on behalf of the International Genomics of Alzheimer’s Project.

BMJ. 2017 Dec 6;359:j5375. doi: 10.1136/bmj.j5375.

19.

Music Intervention With Reminiscence Therapy and Reality Orientation for Elderly People With Alzheimer Disease Living in a Nursing Home: A Pilot Study.

Onieva-Zafra MD, Hernández-Garcia L, Gonzalez-Del-Valle MT, Parra-Fernández ML, Fernandez-Martinez E.

Holist Nurs Pract. 2018 Jan/Feb;32(1):43-50. doi: 10.1097/HNP.0000000000000247.

PMID:
29210877
20.

Alzheimer's Disease: Past, Present, and Future.

Bondi MW, Edmonds EC, Salmon DP.

J Int Neuropsychol Soc. 2017 Oct;23(9-10):818-831. doi: 10.1017/S135561771700100X. Review.

Supplemental Content

Loading ...
Support Center